Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBS-7 (Albuterol Sulfate DPI) in Mild Asthma
NCT01252758Phase 2Withdrawn
- Sponsor
- Acerus Pharmaceuticals
- Start
- Nov 2012
- Primary completion
- Apr 2013
01
Overview
Phase 2, randomised, double-blind trial of TBS-7 in asthma (6 arms), sponsored by Acerus Pharmaceuticals. Primary endpoint: Forced Expiratory Volume in 1 second at 6 hours. Planned start Nov 2012; status: withdrawn.
02
Drugs
TBS-7
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01252758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252758.